Upperton Limited
Upperton Limited
Trading as: Upperton Pharma Solutions
#03833301 • Active
B2bManufacturingServices
Upperton Pharma Solutions is a leading Contract Development and Manufacturing Organisation (CDMO) specializing in the development and manufacturing of pharmaceutical dosage forms. With over 25 years of experience, they provide tailored solutions from pre-clinical development to commercial manufacture.
Founded: 31/08/1999
Industries: Research and experimental development on biotechnology
Website: https://upperton.com
Phone: Subscribe to view
Email: Subscribe to view
Location: Nottingham
Products
- Nasal Drug Products
- Oral Dosage Forms
- Pulmonary Drug Products
Services
- Analytical Services
- Clinical Manufacturing
- Formulation Development
- Preformulation Studies
- Regulatory Support
Financial Snapshot
Last accounts made up to 30 June 2024
Next accounts due 31 March 2026 (10 months)
Cash in Bank £9.12m
↓ -48%
Total Liabilities £19.85m
↑ 1746%
Employees 69
↑ 123%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
---|---|---|---|---|
Jamie Roberts | Director | 11/08/2022 | British | 51 years |
Nicola Kim Whitfield | Director | 11/04/2022 | British | 54 years |
Richard Alan Johnson | Ceo | 31/08/1999 | British | 64 years |
Role:
Director
Appointed:
11/08/2022
Nationality:
British
Age:
51 years
Role:
Director
Appointed:
11/04/2022
Nationality:
British
Age:
54 years
Role:
Ceo
Appointed:
31/08/1999
Nationality:
British
Age:
64 years
People with Significant Control
Name | Nature of Control | Notified On | Nationality |
---|---|---|---|
Crocus Bidco Limited | Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors | 11/04/2022 | United Kingdom |
Nature of Control:
Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors
Notified On:
11/04/2022
Nationality:
United Kingdom
Financial Accounts
Jun 2023 | Jun 2022 | Jun 2021 | |
---|---|---|---|
Income Statement | |||
Turnover | |||
Export Revenue | |||
Sales | |||
Other Operating Income | |||
Other Operating Items | |||
Cost of Sales | |||
Raw Materials & Consumables | |||
Gross Profit | |||
Admin Expenses | |||
Other Operating Charges | |||
Depreciation | |||
R&D Expenses | |||
Operating Profit | |||
EBITDA | |||
Financial Revenue | |||
Financial Expenses | |||
Financial Profit/Loss | |||
Interest Paid | |||
Extraordinary Revenue | |||
Extraordinary Expenses | |||
Net Extraordinary Items | |||
Pre-Tax Profit | |||
Tax | |||
Profit After Tax | |||
Retained Profit | |||
Balance Sheet | |||
Non-Current Assets | |||
Intangible Assets | |||
Tangible Fixed Assets | |||
Other Non-Current Assets | |||
Current Assets | |||
Stock | |||
Debtors | |||
Cash in Hand | |||
Other Current Assets | |||
Called Up Share Capital | |||
P&L Account Reserve | |||
Shareholder Funds | |||
Other Shareholder Funds | |||
Provisions | |||
Long Term Debt | |||
Creditors (> 1 year) | |||
Other Non-Current Liabilities | |||
Short Term Debt | |||
Creditors | |||
Creditors (< 1 year) | |||
Other Current Liabilities | |||
Key Metrics | |||
Net Assets | |||
Net Current Assets | |||
Total Assets Less Current Liabilities | |||
Working Capital | |||
Enterprise Value | |||
Added Value | |||
Cashflow Before D&A | |||
Other Information | |||
Staff Costs | |||
Number of Employees |
Charges
No charges registered
Properties
4 properties
Regions
1
Freehold
0
Leasehold
4
EAST MIDLANDS
Albert Einstein Centre, Nottingham Science & Technology Park, Nottingham (NG7 2TN)
Leasehold • NG7 2TN
Added 02/03/2018 • CITY OF NOTTINGHAM
EAST MIDLANDS
5 Beeston Business Park, Technology Drive, Beeston, Nottingham (NG9 1LA)
Leasehold • NG9 1LA
Added 23/06/2022 • BROXTOWE
EAST MIDLANDS
11 Beeston Business Park, Technology Drive, Beeston, Nottingham (NG9 1LA)
Leasehold • NG9 1LA
Added 23/06/2022 • BROXTOWE
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
Date | Category | Description | Document |
---|---|---|---|
04/04/2025 | Accounts | Accounts With Accounts Type Full | View (20 pages) |
12/07/2024 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
27/03/2024 | Accounts | Accounts With Accounts Type Total Exemption Full | View (12 pages) |
12/03/2024 | Officers | Appoint Person Secretary Company With Name Date | View (2 pages) |
12/03/2024 | Officers | Termination Secretary Company With Name Termination Date | View (1 page) |
17/07/2023 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
29/03/2023 | Accounts | Accounts With Accounts Type Audited Abridged | View (9 pages) |